Journey Medical Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| De Paolantonio Ernest Robert | See Remarks | Sale | 10,093 | $2.41 | $24,324 | 259,907 | Oct 4, 2022 |
| De Paolantonio Ernest Robert | Chief Financial Officer | Sale | 10,093 | $2.41 | $24,324 | 259,907 | Oct 4, 2022 |
| De Paolantonio Ernest Robert | Chief Financial Officer | Award / Grant | 150,000 | — | — | 270,000 | Jul 21, 2022 |
| Maraoui Claude | President & CEO | Award / Grant | 300,000 | — | — | 2,192,530 | Jul 21, 2022 |
| Toledano Miranda Jayne | — | Award / Grant | 14,245 | — | — | 44,245 | Jul 21, 2022 |
| Herskowitz Neil | — | Award / Grant | 14,245 | — | — | 44,245 | Jul 21, 2022 |
| Paley Jeffrey | — | Award / Grant | 14,245 | — | — | 44,245 | Jul 21, 2022 |
| Smith Justin Adam | — | Award / Grant | 14,245 | — | — | 44,245 | Jul 21, 2022 |
| ROSENWALD LINDSAY A MD | — | Award / Grant | 14,245 | — | — | 14,245 | Jul 21, 2022 |
| Fortress Biotech, Inc. | — | Other | 50,000 | — | — | 3,960,467 | May 12, 2022 |
| De Paolantonio Ernest Robert | Chief Financial Officer | Award / Grant | 120,000 | — | — | 120,000 | Jan 14, 2022 |
| Herskowitz Neil | — | Award / Grant | 30,000 | — | — | 30,000 | Jan 14, 2022 |
| Smith Justin Adam | — | Award / Grant | 30,000 | — | — | 30,000 | Jan 14, 2022 |
| Paley Jeffrey | — | Award / Grant | 30,000 | — | — | 30,000 | Jan 14, 2022 |
| Toledano Miranda Jayne | — | Award / Grant | 30,000 | — | — | 30,000 | Jan 14, 2022 |